This hypothesis requires further investigation
Continuous Glucose Monitoring in People at High Risk of Diabetes and Dysglycaemia: Transforming Early Risk Detection and Personalised Care Our latest review explores how continuous glucose monitoring (CGM) could transform early detection and personalised management of diabetes risk Key Highlights: CGM reveals subtle patterns of dysglycaemia in high-risk individuals, including those with pre-symptomatic type 1 diabetes with positive islet autoantibodies, pre-type 2 diabetes or other metabolic dysfunction associated with changes in body composition, metabolic dysfunction-associated steatotic liver disease, gestational diabetes mellitus, solid organ transplantation, steroid treatment CGM-derived data are not yet validated for diabetes diagnosis, and challenges remain including limited evidence, lack of consensus on abnormal CGM values in people without diabetes, and uncertainty about optimal follow-up and management

Clothes fit looser, especially around waist and hips Others may start noticing your weight loss Energy and daily activity levels often improve Eating habits feel more natural and less forced This phase builds confidence and motivation to continue
Take one quick-dissolve tablet as directed by your healthcare practitioner
Results should guide provider conversations about personalized strategies, combined with clinical assessment and biomarker data